Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$11.36 USD
+0.85 (8.09%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $11.37 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Brokerage Reports
Pediatrix Medical Group, Inc. [MD]
Reports for Purchase
Showing records 181 - 200 ( 350 total )
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Reducing Estimates on Soft Volumes/ vRad Constraints
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Reducing Estimates on Soft Volumes/ vRad Constraints
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Termination of Coverage
Provider: DAWSON JAMES SECURITIES, INC.
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Reducing Estimates, but Valuation Is Getting Attractive
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
4Q EPS Slightly Ahead, but EBITDA - Guidance Are a Little Light
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
3Q Results in Line as a Decline in Organic Revenue Is Offset by Record Growth from Acquisitions
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Investor Day Highlights Management Depth - Broadened Product Offering
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Raising Estimates Slightly on 2Q and vRad Acquisition
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
2Q Solidly Ahead as Balance Sheet Fuels Recent M-A - Buyback
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J